ESCCA Industrial Partner Presentations & sponsor events

 

Thursday, 13 September  

 

10:00 - 10:30  Beckman Coulter - ESCCA Industrial Partner Presentation (Auditorio 1)

Mike Keeney, London Health Sciences Centre, London, Canada
Initial evaluation of the ClearLLab 10C System for the immunophenotyping of Leukemia and Lymphoma
ClearLLab 10C: In development, pending achievement of CE compliance; not yet available for in vitro diagnostic use.

 

12:45  Beckman Coulter - Meet the Experts (Sala 2)

Marion Subklewe and Veit Bücklein, Klinikum der Ludwig-Maximilians-Universität München (LMU), Munich, Germany
Multicenter assessment of Flow MRD in AML: The HARMONIZE Initiative

 

15:15  Beckman Coulter - Meet the Experts (Sala 2)

Andy Rawstron, St. James´s University Hospital, Leeds, United Kingdom and Karl-Anton Kreuzer, Universitätsklinikum Köln, Cologne, Germany
Keeping up with new therapies: High sensitivity MRD detection in CLL

 

15:30 - 16:00  BD - ESCCA Industrial Partner Presentation (Auditorio 1)

The difference of transformation

BD is striving to increase automation and standardisation in flow cytometry, transforming your laboratory into a more efficient and effective workplace, for increased reliable and accurate results.
Join us for a special round table discussion and discover how the solutions proposed by BD are making THE difference in the way clinical flow cytometry is experienced.
Discover the difference of transformation.

 

 

Friday, 14 September 

 

10:45  Beckman Coulter - Meet the Experts (Sala 2)

Thomas Matthes, University Hospital Geneva, Geneva, Switzerland
Analysis of the hematopoietic stem cell compartment

  

11:15 - 11:45  Cytognos - ESCCA Industrial Partner Presentation (Auditorio 1)

José Mário Morgado, Innovation Director at Cytognos, S.L.
Embrace Next Generation Flow: A complete solution from sample preparation to expert-guided automated reporting

 

13:15  Beckman Coulter - Meet the Experts (Sala 2) 

Wolfgang Kern, MLL Münchner Leukämielabor GmbH, Munich, Germany
Concepts of sample processing for flow cytometric evaluation of hematologic malignancies including the ClearLLab 10C System
ClearLLab 10C: In development, pending achievement of CE compliance; not yet available for in vitro diagnostic use. 

 

18:00 - 19:00  BD-partnered event (Sala 1)

Transforming cancer screening and diagnosis: real-life testimonials

We are partnering with a cancer patient association to share different players’ experiences along the cancer patient journey: a patient, a clinician, a diagnostic lab manager and a cancer association. Don’t miss it! Reserve your seat on-site at booth PR1 (maximum capacity: 70 people). Aperitif will follow.

 

18:00 - 18:45  Beckman Coulter - Booth Reception (PR3)

Cytometry Slam

Massimo Geuna, Azienda Ospedaliera Ordine Mauriziano di Torino, Turin, Italy
Nizon Plus Lyse & Wash system for automated bulk lysis and cell concentration: a standardized approach to rare event analysis

Frank Preijers, Radboud University Medical Centre, Nijmegen, The Netherlands
A new approach to improve immunephenotyping: Stack the MoAbs to get more combinations

Loris Zamai, Università degli Studi di Urbino Carlo Bo, Urbino, Italy
New flow cytometric approaches to monitor the phenotype of distinct NK cell subsets during their culture and expansion

Francesca Ricci, AOU Sant’Orsola Malpighi di Bologna, Bologna, Italy
Phenotype, function, and apoptosis microRNA of circulating microparticles in patients with Triple-negative Myelofibrosis related to the expression of isolated microparticles of JAK2V617F mutated